Page last updated: 2024-10-20

sulfur dioxide and Airflow Obstruction, Chronic

sulfur dioxide has been researched along with Airflow Obstruction, Chronic in 39 studies

Sulfur Dioxide: A highly toxic, colorless, nonflammable gas. It is used as a pharmaceutical aid and antioxidant. It is also an environmental air pollutant.

Research Excerpts

ExcerptRelevanceReference
"A panel of 23 stable COPD patients was repeatedly measured for biomarkers of airway inflammation including exhaled nitric oxide (FeNO) and exhaled hydrogen sulfide (FeH2S) (215 measurements) and recorded for daily respiratory symptoms (794person-days) in two study periods in Beijing, China in January-September 2014."3.83Short-term exposure to high ambient air pollution increases airway inflammation and respiratory symptoms in chronic obstructive pulmonary disease patients in Beijing, China. ( Baccarelli, AA; Chen, Y; Deng, F; Guo, X; Li, H; Ni, Y; Pan, L; Shima, M; Wu, S; Yang, D, 2016)
"Improvements in knowledge of COPD and smoking hazards, outdoor air quality, environmental tobacco smoke, and working conditions were also achieved (all P<0."2.75Community based integrated intervention for prevention and management of chronic obstructive pulmonary disease (COPD) in Guangdong, China: cluster randomised controlled trial. ( Hu, G; Hu, J; Liu, S; Liu, Z; Lu, J; Peng, G; Ran, P; Shi, Z; Wang, D; Wang, J; Wang, S; Wang, Y; Zheng, J; Zhong, N; Zhou, Y, 2010)
"Chronic Obstructive Pulmonary Disease (COPD) is a common chronic respiratory disease related to inflammation affected by harmful gas and particulate matter in the air."1.56Predicting the morbidity of chronic obstructive pulmonary disease based on multiple locally weighted linear regression model with K-means clustering. ( Cao, JY; Gregersen, H; Huang, ZY; Lin, S; Long, LL; Luo, F; Qin, WC; Sun, DM, 2020)
"Chronic obstructive pulmonary disease (COPD), lung cancer (LC) and tuberculosis (TB) are common chronic lung diseases that generate a large disease burden and significant health care resource use in China."1.51Spatial patterns and effects of air pollution and meteorological factors on hospitalization for chronic lung diseases in Beijing, China. ( Clements, ACA; Pan, X; Tian, L; Wu, Z; Yang, C; Zhou, Z, 2019)
"A total of 309 acute COPD exacerbations (AECOPD) were recorded in the analysis."1.46Impact of Air Pollution and Outdoor Temperature on the Rate of Chronic Obstructive Pulmonary Disease Exacerbations. ( Borisova, ED; Hristova, PA; Ivanov, YY; Ivanova, ZI; Krachunov, II; Kyuchukov, NH; Nikolova, PT; Pavlov, PS; Popova, TP; Yanev, NA, 2017)
"Chronic obstructive pulmonary disease (COPD) is an important disease worldwide characterized by chronically poor airflow."1.43Evaluation of Chronic Obstructive Pulmonary Disease (COPD) attributed to atmospheric O3, NO2, and SO2 using Air Q Model (2011-2012 year). ( Ferrante, M; Ghanbari Ghozikali, M; Heibati, B; Kloog, I; Naddafi, K; Oliveri Conti, G; Polosa, R, 2016)
"Few studies have investigated the chronic obstructive pulmonary disease (COPD) mortality fraction attributable to air pollution and modification by individual characteristics of air pollution effects."1.43The burden of COPD mortality due to ambient air pollution in Guangzhou, China. ( Chen, PY; Li, L; Ou, CQ; Song, YF; Yang, J, 2016)
"Chronic obstructive pulmonary disease (COPD) is a prevalent condition in adults aged ≥40 years characterized by progressive airflow limitation associated with chronic inflammatory response to noxious particles in the airways and lungs."1.43Exacerbations of Chronic Obstructive Pulmonary Disease (COPD): An Ecological Study in the Basque Country, Spain (2000-2011). ( Altzibar, JM; Dorronsoro, M; Mughini-Gras, L; Tamayo-Uria, I, 2016)
"Exacerbations of chronic obstructive pulmonary disease (COPD) contribute greatly to increased morbidity, mortality and diminished quality of life."1.43Low level air pollution and exacerbation of existing copd: a case crossover analysis. ( DeVries, R; Kriebel, D; Sama, S, 2016)
"First COPD diagnoses recorded either by a general practitioner (GP) or on admission to hospital were identified."1.42Long-term exposure to outdoor air pollution and the incidence of chronic obstructive pulmonary disease in a national English cohort. ( Anderson, HR; Atkinson, RW; Carey, IM; Cook, DG; Kent, AJ; van Staa, TP, 2015)
"Acute exacerbations of COPD (AECOPD) are important events during disease procedure."1.42A GIS-based spatial correlation analysis for ambient air pollution and AECOPD hospitalizations in Jinan, China. ( Ma, D; Wang, W; Wu, Q; Xiao, W; Ying, Y; Zhang, H, 2015)
"Hospital admissions for RD including chronic obstructive pulmonary disease (COPD), asthma, and pneumonia, and ambient air pollution data levels for Kaohsiung were obtained for the period from 2006 to 2010."1.42Coarse Particulate Air Pollution Associated with Increased Risk of Hospital Admissions for Respiratory Diseases in a Tropical City, Kaohsiung, Taiwan. ( Cheng, MH; Chiu, HF; Yang, CY, 2015)
"Patients with chronic obstructive pulmonary disease (COPD) can have recurrent disease exacerbations triggered by several factors, including air pollution."1.35Urban air pollution and chronic obstructive pulmonary disease-related emergency department visits. ( Arbex, FF; Arbex, MA; Braga, AL; Cendon, SP; de Souza Conceição, GM; Lopes, AC; Moysés, EP; Pereira, LA; Saldiva, PH; Santiago, SL, 2009)
"Hospital admissions for COPD and ambient air pollution data for Kaohsiung were obtained for the period from 1996 to 2003."1.34Air pollution and hospital admissions for chronic obstructive pulmonary disease in a tropical city: Kaohsiung, Taiwan. ( Chang, CC; Ho, CK; Lee, IM; Tsai, SS; Yang, CY, 2007)
"The association of ED visits for asthma/COPD with month of the year was stronger than associations seen with air quality."1.32Emergency department visits and "vog"-related air quality in Hilo, Hawai'i. ( Grove, JS; Krupitsky, D; Michaud, JP, 2004)
"change of airway functions and hypoxemia, were examined using guinea pigs with induced subacute bronchitis."1.31Effect of YM-40461, a novel surfactant secretagogue, on chronic obstructive pulmonary diseases and similar symptoms in guinea pigs. ( Hirano, Y; Iwai, T; Kimoto, A; Miyata, K; Saito, M; Yamada, T, 2001)
"To establish rat models of chronic obstructive pulmonary disease (COPD) and study the pathological characteristics of airflow obstruction."1.31Establishment and pathological study of models of chronic obstructive pulmonary disease by SO2 inhalation method. ( Liao, S; Xu, J; Zhao, M, 2000)
"A rat model of COPD with pathophysiologic changes similar to the human counterpart was developed using chronic SO2 exposure."1.31Effect of ipratropium bromide on airway and pulmonary muscarinic receptors in a rat model of chronic obstructive pulmonary disease. ( Sun, Y; Wang, G; Yao, W; Zhao, M; Zhu, H, 2001)

Research

Studies (39)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's13 (33.33)29.6817
2010's23 (58.97)24.3611
2020's3 (7.69)2.80

Authors

AuthorsStudies
Jung, YJ1
Kim, EJ1
Heo, JY1
Choi, YH1
Kim, DJ1
Ha, KH1
Raji, H1
Riahi, A1
Borsi, SH1
Masoumi, K1
Khanjani, N1
AhmadiAngali, K1
Goudarzi, G1
Dastoorpoor, M1
Halim, AA1
Alsayed, B1
Embarak, S1
Yaseen, T1
Dabbous, S1
Fontaine, O1
Dueluzeau, R1
Raibaud, P1
Chabanet, C1
Popoff, MR1
Badoual, J1
Gabilan, JC1
Andremont, A1
Gómez, L1
Andrés, S1
Sánchez, J1
Alonso, JM1
Rey, J1
López, F1
Jiménez, A1
Yan, Z1
Zhou, L1
Zhao, Y3
Wang, J7
Huang, L2
Hu, K1
Liu, H4
Wang, H3
Guo, Z1
Song, Y1
Huang, H4
Yang, R1
Owen, TW1
Al-Kaysi, RO1
Bardeen, CJ1
Cheng, Q1
Wu, S2
Cheng, T1
Zhou, X1
Wang, B4
Zhang, Q5
Wu, X2
Yao, Y3
Ochiai, T1
Ishiguro, H2
Nakano, R2
Kubota, Y2
Hara, M1
Sunada, K1
Hashimoto, K1
Kajioka, J1
Fujishima, A1
Jiao, J3
Gai, QY3
Wang, W3
Zang, YP2
Niu, LL2
Fu, YJ3
Wang, X5
Yao, LP1
Qin, QP1
Wang, ZY1
Liu, J4
Aleksic Sabo, V1
Knezevic, P1
Borges-Argáez, R1
Chan-Balan, R1
Cetina-Montejo, L1
Ayora-Talavera, G1
Sansores-Peraza, P1
Gómez-Carballo, J1
Cáceres-Farfán, M1
Jang, J1
Akin, D1
Bashir, R1
Yu, Z1
Zhu, J2
Jiang, H1
He, C2
Xiao, Z1
Xu, J3
Sun, Q1
Han, D1
Lei, H1
Zhao, K2
Zhu, L1
Li, X5
Fu, H2
Wilson, BK1
Step, DL1
Maxwell, CL1
Gifford, CA1
Richards, CJ1
Krehbiel, CR1
Warner, JM1
Doerr, AJ1
Erickson, GE1
Guretzky, JA1
Rasby, RJ1
Watson, AK1
Klopfenstein, TJ1
Sun, Y5
Liu, Z4
Pham, TD1
Lee, BK1
Yang, FC1
Wu, KH1
Lin, WP1
Hu, MK1
Lin, L3
Shao, J1
Sun, M1
Xu, G1
Zhang, X6
Xu, N1
Wang, R1
Liu, S2
He, H1
Dong, X2
Yang, M2
Yang, Q1
Duan, S1
Yu, Y2
Han, J2
Zhang, C3
Chen, L2
Yang, X1
Li, W3
Wang, T2
Campbell, DA1
Gao, K1
Zager, RA1
Johnson, ACM1
Guillem, A1
Keyser, J1
Singh, B1
Steubl, D1
Schneider, MP1
Meiselbach, H1
Nadal, J1
Schmid, MC1
Saritas, T1
Krane, V1
Sommerer, C1
Baid-Agrawal, S1
Voelkl, J1
Kotsis, F1
Köttgen, A1
Eckardt, KU1
Scherberich, JE1
Li, H5
Yao, L2
Sun, L3
Zhu, Z1
Naren, N1
Zhang, XX2
Gentile, GL1
Rupert, AS1
Carrasco, LI1
Garcia, EM1
Kumar, NG1
Walsh, SW1
Jefferson, KK1
Guest, RL1
Samé Guerra, D1
Wissler, M1
Grimm, J1
Silhavy, TJ1
Lee, JH2
Yoo, JS1
Kim, Y1
Kim, JS2
Lee, EJ1
Roe, JH1
Delorme, M1
Bouchard, PA1
Simon, M1
Simard, S1
Lellouche, F1
D'Urzo, KA1
Mok, F1
D'Urzo, AD1
Koneru, B1
Lopez, G1
Farooqi, A1
Conkrite, KL1
Nguyen, TH1
Macha, SJ1
Modi, A1
Rokita, JL1
Urias, E1
Hindle, A1
Davidson, H1
Mccoy, K1
Nance, J1
Yazdani, V1
Irwin, MS1
Yang, S1
Wheeler, DA1
Maris, JM1
Diskin, SJ1
Reynolds, CP1
Abhilash, L1
Kalliyil, A1
Sheeba, V1
Hartley, AM2
Meunier, B2
Pinotsis, N1
Maréchal, A2
Xu, JY1
Genko, N1
Haraux, F1
Rich, PR1
Kamalanathan, M1
Doyle, SM1
Xu, C1
Achberger, AM1
Wade, TL1
Schwehr, K1
Santschi, PH1
Sylvan, JB1
Quigg, A1
Leong, W1
Xu, W2
Gao, S1
Zhai, X1
Wang, C2
Gilson, E1
Ye, J1
Lu, Y1
Yan, R1
Zhang, Y6
Hu, Z1
You, Q1
Cai, Q1
Yang, D2
Gu, S1
Dai, H1
Zhao, X1
Gui, C1
Gui, J1
Wu, PK1
Hong, SK1
Starenki, D1
Oshima, K1
Shao, H1
Gestwicki, JE1
Tsai, S1
Park, JI1
Wang, Y8
Zhao, R1
Gu, Z1
Dong, C2
Guo, G1
Li, L5
Barrett, HE1
Meester, EJ1
van Gaalen, K1
van der Heiden, K1
Krenning, BJ1
Beekman, FJ1
de Blois, E1
de Swart, J1
Verhagen, HJ1
Maina, T1
Nock, BA1
Norenberg, JP1
de Jong, M1
Gijsen, FJH1
Bernsen, MR1
Martínez-Milla, J1
Galán-Arriola, C1
Carnero, M1
Cobiella, J1
Pérez-Camargo, D1
Bautista-Hernández, V1
Rigol, M1
Solanes, N1
Villena-Gutierrez, R1
Lobo, M1
Mateo, J1
Vilchez-Tschischke, JP1
Salinas, B1
Cussó, L1
López, GJ1
Fuster, V1
Desco, M1
Sanchez-González, J1
Ibanez, B1
van den Berg, P1
Schweitzer, DH1
van Haard, PMM1
Geusens, PP1
van den Bergh, JP1
Zhu, X1
Huang, X2
Xu, H2
Yang, G2
Lin, Z1
Salem, HF1
Nafady, MM1
Kharshoum, RM1
Abd El-Ghafar, OA1
Farouk, HO1
Domiciano, D1
Nery, FC1
de Carvalho, PA1
Prudente, DO1
de Souza, LB1
Chalfun-Júnior, A1
Paiva, R1
Marchiori, PER1
Lu, M2
An, Z1
Jiang, J2
Li, J7
Du, S1
Zhou, H1
Cui, J1
Wu, W1
Liu, Y8
Song, J1
Lian, Q1
Uddin Ahmad, Z1
Gang, DD1
Konggidinata, MI1
Gallo, AA1
Zappi, ME1
Yang, TWW1
Johari, Y1
Burton, PR1
Earnest, A1
Shaw, K1
Hare, JL1
Brown, WA1
Kim, GA1
Han, S1
Choi, GH1
Choi, J1
Lim, YS1
Gallo, A1
Cancelli, C1
Ceron, E1
Covino, M1
Capoluongo, E1
Pocino, K1
Ianiro, G1
Cammarota, G1
Gasbarrini, A1
Montalto, M1
Somasundar, Y1
Lu, IC1
Mills, MR1
Qian, LY1
Olivares, X1
Ryabov, AD1
Collins, TJ1
Zhao, L1
Doddipatla, S1
Thomas, AM1
Nikolayev, AA1
Galimova, GR1
Azyazov, VN1
Mebel, AM1
Kaiser, RI1
Guo, S1
Yang, P1
Yu, X2
Wu, Y2
Zhang, H2
Yu, B2
Han, B1
George, MW1
Moor, MB1
Bonny, O1
Langenberg, E1
Paik, H1
Smith, EH1
Nair, HP1
Hanke, I1
Ganschow, S1
Catalan, G1
Domingo, N1
Schlom, DG1
Assefa, MK1
Wu, G2
Hayton, TW1
Becker, B1
Enikeev, D1
Netsch, C1
Gross, AJ1
Laukhtina, E1
Glybochko, P1
Rapoport, L1
Herrmann, TRW1
Taratkin, M1
Dai, W1
Shi, J2
Carreno, J1
Kloner, RA1
Pickersgill, NA1
Vetter, JM1
Kim, EH1
Cope, SJ1
Du, K1
Venkatesh, R1
Giardina, JD1
Saad, NES1
Bhayani, SB1
Figenshau, RS1
Eriksson, J1
Landfeldt, E1
Ireland, S1
Jackson, C1
Wyatt, E1
Gaudig, M1
Stancill, JS1
Happ, JT1
Broniowska, KA1
Hogg, N1
Corbett, JA1
Tang, LF1
Bi, YL1
Fan, Y2
Sun, YB1
Wang, AL1
Xiao, BH1
Wang, LF1
Qiu, SW1
Guo, SW1
Wáng, YXJ1
Sun, J3
Chu, S1
Pan, Q1
Li, D2
Zheng, S2
Ma, L1
Wang, L3
Hu, T1
Wang, F1
Han, Z1
Yin, Z1
Ge, X1
Xie, K1
Lei, P1
Dias-Santagata, D1
Lennerz, JK1
Sadow, PM1
Frazier, RP1
Govinda Raju, S1
Henry, D1
Chung, T1
Kherani, J1
Rothenberg, SM1
Wirth, LJ1
Marti, CN1
Choi, NG1
Bae, SJ1
Ni, L1
Luo, X1
Dai, T1
Yang, Y3
Lee, R1
Fleischer, AS1
Wemhoff, AP1
Ford, CR1
Kleppinger, EL1
Helms, K1
Bush, AA1
Luna-Abanto, J1
García Ruiz, L1
Laura Martinez, J1
Álvarez Larraondo, M1
Villoslada Terrones, V1
Dukic, L1
Maric, N1
Simundic, AM1
Chogtu, B1
Ommurugan, B1
Thomson, SR1
Kalthur, SG1
Benidir, M1
El Massoudi, S1
El Ghadraoui, L1
Lazraq, A1
Benjelloun, M1
Errachidi, F1
Cassar, M1
Law, AD1
Chow, ES1
Giebultowicz, JM1
Kretzschmar, D1
Salonurmi, T1
Nabil, H1
Ronkainen, J1
Hyötyläinen, T1
Hautajärvi, H1
Savolainen, MJ1
Tolonen, A1
Orešič, M1
Känsäkoski, P1
Rysä, J1
Hakkola, J1
Hukkanen, J1
Zhu, N1
Li, Y4
Du, Q1
Hao, P1
Cao, X1
Li, CX1
Zhao, S1
Luo, XM1
Feng, JX1
Gonzalez-Cotto, M1
Guo, L1
Karwan, M1
Sen, SK1
Barb, J1
Collado, CJ1
Elloumi, F1
Palmieri, EM1
Boelte, K1
Kolodgie, FD1
Finn, AV1
Biesecker, LG1
McVicar, DW1
Qu, F1
Deng, Z1
Xie, Y2
Tang, J3
Chen, Z2
Luo, W1
Xiong, D1
Zhao, D1
Fang, J1
Zhou, Z2
Niu, PP1
Song, B1
Xu, YM1
Zhang, Z2
Qiu, N1
Yin, J1
Zhang, J3
Guo, W1
Liu, M2
Liu, T2
Chen, D5
Luo, K1
He, Z2
Zheng, G1
Xu, F1
Sun, W1
Yin, F1
van Hest, JCM1
Du, L2
Shi, X1
Kang, S1
Duan, W1
Zhang, S2
Feng, J2
Qi, N1
Shen, G2
Ren, H1
Shang, Q1
Zhao, W2
Yang, Z2
Jiang, X2
Alame, M1
Cornillot, E1
Cacheux, V1
Tosato, G1
Four, M1
De Oliveira, L1
Gofflot, S1
Delvenne, P1
Turtoi, E1
Cabello-Aguilar, S1
Nishiyama, M1
Turtoi, A1
Costes-Martineau, V1
Colinge, J1
Guo, Q1
Quan, M1
Dong, J1
Bai, J1
Han, R1
Cai, Y1
Lv, YQ1
Chen, Q1
Lyu, HD1
Deng, L1
Zhou, D1
Xiao, X1
De Langhe, S1
Billadeau, DD1
Lou, Z1
Zhang, JS1
Xue, Z1
Shen, XD1
Gao, F1
Busuttil, RW1
Kupiec-Weglinski, JW1
Ji, H1
Otano, I1
Alvarez, M1
Minute, L1
Ochoa, MC1
Migueliz, I1
Molina, C1
Azpilikueta, A1
de Andrea, CE1
Etxeberria, I1
Sanmamed, MF1
Teijeira, Á1
Berraondo, P1
Melero, I1
Zhong, Z1
Xie, X2
Yu, Q1
Zhou, C1
Liu, C2
Liu, W1
Chen, W1
Yin, Y1
Li, CW1
Hsu, JL1
Zhou, Q1
Hu, B1
Fu, P1
Atyah, M1
Ma, Q2
Xu, Y1
Dong, Q1
Hung, MC1
Ren, N1
Huang, P1
Liao, R1
Chen, X3
Cao, Q1
Yuan, X1
Nie, W1
Yang, J3
Shao, B1
Ma, X1
Bi, Z1
Liang, X1
Tie, Y1
Mo, F1
Xie, D1
Wei, Y1
Wei, X2
Dokla, EME1
Fang, CS1
Chu, PC1
Chang, CS1
Abouzid, KAM1
Chen, CS1
Blaszczyk, R1
Brzezinska, J1
Dymek, B1
Stanczak, PS1
Mazurkiewicz, M1
Olczak, J1
Nowicka, J1
Dzwonek, K1
Zagozdzon, A1
Golab, J1
Golebiowski, A1
Xin, Z1
Himmelbauer, MK1
Jones, JH1
Enyedy, I1
Gilfillan, R1
Hesson, T1
King, K1
Marcotte, DJ1
Murugan, P1
Santoro, JC1
Gonzalez-Lopez de Turiso, F1
Pedron, J1
Boudot, C1
Brossas, JY1
Pinault, E1
Bourgeade-Delmas, S1
Sournia-Saquet, A1
Boutet-Robinet, E1
Destere, A1
Tronnet, A1
Bergé, J1
Bonduelle, C1
Deraeve, C1
Pratviel, G1
Stigliani, JL1
Paris, L1
Mazier, D1
Corvaisier, S1
Since, M1
Malzert-Fréon, A1
Wyllie, S1
Milne, R1
Fairlamb, AH1
Valentin, A1
Courtioux, B1
Verhaeghe, P1
Fang, X1
Gao, M1
Gao, H1
Bi, W1
Tang, H1
Cui, Y1
Zhang, L3
Fan, H1
Yu, H1
Mathison, CJN1
Chianelli, D1
Rucker, PV1
Nelson, J1
Roland, J1
Huang, Z2
Xie, YF1
Epple, R1
Bursulaya, B1
Lee, C1
Gao, MY1
Shaffer, J1
Briones, S1
Sarkisova, Y1
Galkin, A1
Li, N1
Li, C2
Hua, S1
Kasibhatla, S1
Kinyamu-Akunda, J1
Kikkawa, R1
Molteni, V1
Tellew, JE1
Jin, X1
Pang, B1
Liu, Q3
Liu, X3
Huang, Y2
Josephine Fauci, A1
Ma, Y1
Soo Lee, M1
Yuan, W1
Gao, R1
Qi, H1
Zheng, W1
Yang, F2
Chua, H1
Wang, K1
Ou, Y1
Huang, M1
Zhu, Y1
Yu, J1
Tian, J1
Zhao, M4
Hu, J2
Yao, C1
Zhang, B1
Usawachintachit, M1
Tzou, DT1
Washington, SL1
Hu, W1
Chi, T1
Sorensen, MD1
Bailey, MR1
Hsi, RS1
Cunitz, BW1
Simon, J1
Wang, YN1
Dunmire, BL1
Paun, M1
Starr, F1
Lu, W1
Evan, AP1
Harper, JD1
Han, G1
Rodrigues, AE1
Fouladvand, F1
Falahi, E1
Asbaghi, O1
Abbasnezhad, A1
Anigboro, AA1
Avwioroko, OJ1
Cholu, CO1
Sonei, A1
Fazelipour, S1
Kanaani, L1
Jahromy, MH1
Jo, K1
Hong, KB1
Suh, HJ1
Park, JH1
Shin, E1
Park, E1
Kouakou-Kouamé, CA1
N'guessan, FK1
Montet, D1
Djè, MK1
Kim, GD1
González-Fernández, D1
Pons, EDC1
Rueda, D1
Sinisterra, OT1
Murillo, E1
Scott, ME1
Koski, KG1
Shete, PB1
Gonzales, R1
Ackerman, S1
Cattamanchi, A1
Handley, MA1
Li, XX1
Xiao, SZ1
Gu, FF1
He, WP1
Ni, YX1
Han, LZ1
Heffernan, JK1
Valgepea, K1
de Souza Pinto Lemgruber, R1
Casini, I1
Plan, M1
Tappel, R1
Simpson, SD1
Köpke, M1
Nielsen, LK1
Marcellin, E1
Cen, YK1
Lin, JG1
Wang, YL1
Wang, JY1
Liu, ZQ1
Zheng, YG1
Spirk, D1
Noll, S1
Burnier, M1
Rimoldi, S1
Noll, G1
Sudano, I1
Penzhorn, BL1
Oosthuizen, MC1
Kobos, LM1
Alqatani, S1
Ferreira, CR1
Aryal, UK1
Hedrick, V1
Sobreira, TJP1
Shannahan, JH1
Gale, P1
Singhroy, DN1
MacLean, E1
Kohli, M1
Lessem, E1
Branigan, D1
England, K1
Suleiman, K1
Drain, PK1
Ruhwald, M1
Schumacher, S1
Denkinger, CM1
Waning, B1
Van Gemert, W1
Pai, M1
Myers, RK1
Bonsu, JM1
Carey, ME1
Yerys, BE1
Mollen, CJ1
Curry, AE1
Douglas, TA1
Alinezhadbalalami, N1
Balani, N1
Schmelz, EM1
Davalos, RV1
Kamaldinov, T1
Erndt-Marino, J1
Levin, M1
Kaplan, DL1
Hahn, MS1
Heidarimoghadam, R1
Farmany, A1
Lee, JJ1
Kang, J1
Park, S1
Cho, JH1
Oh, S1
Park, DJ1
Perez-Maldonado, R1
Cho, JY1
Park, IH1
Kim, HB1
Song, M1
Mfarrej, B1
Jofra, T1
Morsiani, C1
Gagliani, N1
Fousteri, G1
Battaglia, M1
Giuliano, C1
Levinger, I1
Vogrin, S1
Neil, CJ1
Allen, JD1
Lv, Y1
Yuan, R1
Cai, B1
Bahrami, B1
Chowdhury, AH1
Yang, C3
Qiao, Q1
Liu, SF1
Zhang, WH1
Kolano, L1
Knappe, D1
Volke, D1
Sträter, N1
Hoffmann, R1
Coussens, M1
Calders, P1
Lapauw, B1
Celie, B1
Banica, T1
De Wandele, I1
Pacey, V1
Malfait, F1
Rombaut, L1
Vieira, D1
Angel, S1
Honjol, Y1
Gruenheid, S1
Gbureck, U1
Harvey, E1
Merle, G1
Seo, G1
Lee, G1
Kim, MJ1
Baek, SH1
Choi, M1
Ku, KB1
Lee, CS1
Jun, S1
Park, D1
Kim, HG1
Kim, SJ1
Lee, JO1
Kim, BT1
Park, EC1
Kim, SI1
Ende, M1
Kirkkala, T1
Loitzenbauer, M1
Talla, D1
Wildner, M1
Miletich, R1
Criado, A1
Lavela, P1
Tirado, JL1
Pérez-Vicente, C1
Kang, D1
Feng, D2
Fang, Z1
Wei, F1
De Clercq, E1
Pannecouque, C1
Zhan, P1
Guo, Y1
Shen, Y1
Wang, Q2
Kawazoe, Y1
Jena, P1
Sun, Z1
Li, Z2
Liang, H1
Xu, X1
Ma, G1
Huo, X1
Church, JS1
Chace-Donahue, F1
Blum, JL1
Ratner, JR1
Zelikoff, JT1
Schwartzer, JJ1
Fiseha, T1
Tamir, Z1
Yao, W2
Wang, P1
Mi, K1
Cheng, J1
Gu, C1
Huang, J3
Sun, HB1
Xing, WQ1
Liu, XB1
Zheng, Y1
Yang, SJ1
Wang, ZF1
Liu, SL1
Ba, YF1
Zhang, RX1
Liu, BX1
Fan, CC1
Chen, PN1
Liang, GH1
Yu, YK1
Wang, HR1
Li, HM1
Li, ZX1
Lalani, SS1
Anasir, MI1
Poh, CL1
Khan, IT1
Nadeem, M1
Imran, M1
Khalique, A1
Raspini, B1
Porri, D1
De Giuseppe, R1
Chieppa, M1
Liso, M1
Cerbo, RM1
Civardi, E1
Garofoli, F1
Monti, MC1
Vacca, M1
De Angelis, M1
Cena, H1
Kong, D1
Han, X1
Zhou, Y4
Xue, H1
Zhang, W1
Ruan, Z1
Li, S2
Noer, PR1
Kjaer-Sorensen, K1
Juhl, AK1
Goldstein, A1
Ke, C1
Oxvig, C1
Duan, C1
Kong, F1
Lin, S2
Wang, Z2
Bhattacharya, R1
Mazumder, D1
Yan, X1
Ma, C1
Tang, Y1
Kong, X1
Lu, J2
Zhang, M1
Vital-Jacome, M1
Cazares-Granillo, M1
Carrillo-Reyes, J1
Buitron, G1
Jacob, SI1
Douair, I1
Maron, L1
Ménard, G1
Rusjan, P1
Sabioni, P1
Di Ciano, P1
Mansouri, E1
Boileau, I1
Laveillé, A1
Capet, M1
Duvauchelle, T1
Schwartz, JC1
Robert, P1
Le Foll, B1
Xia, Y1
Chen, S1
Luo, M1
Wu, J1
Cai, S1
He, Y2
Garbacz, P1
Misiak, M1
Jackowski, K1
Yuan, Q1
Sherrell, PC1
Chen, J3
Bi, X1
Nutho, B1
Mahalapbutr, P1
Hengphasatporn, K1
Pattaranggoon, NC1
Simanon, N1
Shigeta, Y1
Hannongbua, S1
Rungrotmongkol, T1
Caffrey, PJ1
Kher, R1
Bian, K1
Delaney, S1
Xue, J1
Wu, P1
Xu, L1
Yuan, Y1
Luo, J1
Ye, S1
Ustriyana, P1
Wei, B1
Raee, E1
Hu, Y1
Wesdemiotis, C1
Sahai, N1
Kaur, A1
Nigam, K1
Srivastava, S1
Tyagi, A1
Dang, S1
Millar, JE1
Bartnikowski, N1
Passmore, MR1
Obonyo, NG1
Malfertheiner, MV1
von Bahr, V1
Redd, MA1
See Hoe, L1
Ki, KK1
Pedersen, S1
Boyle, AJ1
Baillie, JK1
Shekar, K1
Palpant, N1
Suen, JY1
Matthay, MA1
McAuley, DF1
Fraser, JF1
Settles, JA1
Gerety, GF1
Spaepen, E1
Suico, JG1
Child, CJ1
Oh, BL1
Lee, JS1
Lee, EY1
Lee, HY1
Yu, HG1
Leslie, I1
Boos, LA1
Larkin, J1
Pickering, L1
Lima, HK1
Vogel, K1
Hampel, D1
Wagner-Gillespie, M1
Fogleman, AD1
Ferraz, SL1
O'Connor, M1
Mazzucchelli, TG1
Kajiyama, H1
Suzuki, S1
Shimbo, A1
Utsumi, F1
Yoshikawa, N1
Kikkawa, F1
Javvaji, PK1
Dhali, A1
Francis, JR1
Kolte, AP1
Roy, SC1
Selvaraju, S1
Mech, A1
Sejian, V1
DeSilva, S1
Vaidya, SS1
Mao, C1
Akhatayeva, Z1
Cheng, H1
Zhang, G1
Jiang, F1
Meng, X1
Elnour, IE1
Lan, X1
Song, E1
Rohde, S1
Antonides, CFJ1
Muslem, R1
de Woestijne, PCV1
der Meulen, MHV1
Kraemer, US1
Dalinghaus, M1
Bogers, AJJC1
Pourmand, A1
Ghassemi, M1
Sumon, K1
Amini, SB1
Hood, C1
Sikka, N1
Duan, H1
Chen, WP1
Fan, M1
Wang, WP1
Yu, L1
Tan, SJ1
Xin, S1
Wan, LJ1
Guo, YG1
Tanda, S1
Gingl, K1
Ličbinský, R1
Hegrová, J1
Goessler, W1
Li, ZL1
Zhou, YL1
Yan, W1
Luo, L1
Su, ZZ1
Fan, MZ1
Wang, SR1
Zhao, WG1
Xu, D2
Hassan, HM1
Jiang, Z1
Bachmann, KF1
Haenggi, M1
Jakob, SM1
Takala, J1
Gattinoni, L1
Berger, D1
Bentley, RF1
Vecchiarelli, E1
Banks, L1
Gonçalves, PEO1
Thomas, SG1
Goodman, JM1
Mather, K1
Boachie, R1
Anini, Y1
Panahi, S1
Anderson, GH1
Luhovyy, BL1
Nafie, MS1
Arafa, K1
Sedky, NK1
Alakhdar, AA1
Arafa, RK1
Fan, S1
Hu, H1
Liang, J1
Hu, BC1
Wen, Z1
Hu, D1
Liu, YY1
Chu, Q1
Wu, MC1
Lu, X1
Wang, D2
Hu, M1
Shen, H1
Yao, M1
Dahlgren, RA1
Vysloužil, J1
Kulich, P1
Zeman, T1
Vaculovič, T1
Tvrdoňová, M1
Mikuška, P1
Večeřa, Z1
Stráská, J1
Moravec, P1
Balcar, VJ1
Šerý, O1
Qiao, L1
Xiong, X1
Peng, X1
Zheng, J2
Duan, J1
Xiao, W2
Zhou, HY1
Sui, ZY1
Zhao, FL1
Sun, YN1
Wang, HY1
Han, BH1
Jintao, X1
Shasha, Y1
Jincai, W1
Chunyan, L1
Mengya, Y1
Yongli, S1
Rasoanirina, BNV1
Lassoued, MA1
Miladi, K1
Razafindrakoto, Z1
Chaâbane-Banaoues, R1
Ramanitrahasimbola, D1
Cornet, M1
Sfar, S1
Liang, C1
Xing, Q1
Yi, JL1
Zhang, YQ1
Li, CY1
Tang, SJ1
Gao, C1
Sun, X2
Peng, M1
Sun, XF1
Zhang, T1
Shi, JH1
Liao, CX1
Gao, WJ1
Sun, LL1
Gao, Y2
Cao, WH1
Lyu, J1
Yu, CQ1
Wang, SF1
Pang, ZC1
Cong, LM1
Dong, Z1
Wu, F1
Wu, XP1
Jiang, GH1
Wang, XJ1
Wang, BY1
Li, LM1
Pan, L2
Wan, SP1
Yi, HWL1
He, HJ1
Yong, ZP1
Shan, GL1
Weng, TT1
Yan, SQ1
Gao, GP1
Wei, C1
Tao, FB1
Shao, ZH1
Yao, T1
Dong, S1
Shi, S1
Feng, YL1
Zhang, YW1
Wang, SP1
Shi, AX1
Operario, D1
Zhang, ZH1
Zhu, XF1
Zaller, N1
Gao, P1
Sun, YH1
Zhang, HB1
Huang, ZY1
Long, LL1
Cao, JY1
Luo, F1
Qin, WC1
Sun, DM1
Gregersen, H1
Chang, JH1
Hsu, SC1
Bai, KJ1
Huang, SK1
Hsu, CW1
Krachunov, II1
Kyuchukov, NH1
Ivanova, ZI1
Yanev, NA1
Hristova, PA1
Borisova, ED1
Popova, TP1
Pavlov, PS1
Nikolova, PT1
Ivanov, YY1
Gou, Y1
Yuan, Z1
Kong, L1
Xue, F1
Garcia-Olivé, I2
Stojanovic, Z1
Radua, J2
Rodriguez-Pons, L1
Martinez-Rivera, C1
Ruiz Manzano, J1
Chen, Y2
Zang, L1
Du, W1
Zou, Q1
Yao, D1
Tian, L2
Wu, Z1
Pan, X2
Clements, ACA1
Atkinson, RW1
Carey, IM1
Kent, AJ1
van Staa, TP1
Anderson, HR1
Cook, DG1
Ghozikali, MG1
Mosaferi, M1
Safari, GH1
Jaafari, J1
Ying, Y1
Wu, Q1
Ma, D1
Cheng, MH1
Chiu, HF1
Yang, CY2
Ghanbari Ghozikali, M1
Heibati, B1
Naddafi, K1
Kloog, I1
Oliveri Conti, G1
Polosa, R1
Ferrante, M1
Song, YF1
Chen, PY1
Ou, CQ1
Ni, Y1
Baccarelli, AA1
Deng, F1
Shima, M1
Guo, X2
Tamayo-Uria, I1
Altzibar, JM1
Mughini-Gras, L1
Dorronsoro, M1
Fiz, JA1
Sanz-Santos, J1
Ruiz-Manzano, J1
DeVries, R1
Kriebel, D1
Sama, S1
Li, R1
Jiang, N1
Liu, F1
Gao, Z1
Milutinović, S1
Nikić, D1
Stosić, L1
Stanković, A1
Bogdanović, D1
Arbex, MA1
de Souza Conceição, GM1
Cendon, SP1
Arbex, FF1
Lopes, AC1
Moysés, EP1
Santiago, SL1
Saldiva, PH1
Pereira, LA1
Braga, AL1
Wood, AM1
Harrison, RM1
Semple, S1
Ayres, JG2
Stockley, RA1
Amiot, N1
Tillon, J1
Viacroze, C1
Aouine, H1
Muir, JF1
Hu, G1
Wang, S1
Shi, Z1
Peng, G1
Zhong, N1
Ran, P1
Tam, WW1
Wong, TW3
Wong, AH1
Hui, DS2
Qiu, H1
Yu, IT1
Tse, LA1
Tam, W2
Masjedi, MR1
Jamaati, HR1
Dokouhaki, P1
Ahmadzadeh, Z1
Taheri, SA1
Bigdeli, M1
Izadi, S1
Rostamian, A1
Aagin, K1
Ghavam, SM1
Sunyer, J1
Atkinson, R1
Ballester, F1
Le Tertre, A1
Forastiere, F1
Forsberg, B1
Vonk, JM1
Bisanti, L1
Anderson, RH1
Schwartz, J1
Katsouyanni, K1
Chang, G1
Michaud, JP1
Grove, JS1
Krupitsky, D1
Chen, B1
Hong, C1
Kan, H1
Peel, JL1
Metzger, KB1
Klein, M1
Flanders, WD1
Mulholland, JA1
Tolbert, PE1
Ko, FW1
Chan, DP1
Tung, AH1
Lai, CK1
Lee, IM1
Tsai, SS1
Chang, CC1
Ho, CK1
Kimoto, A1
Saito, M1
Hirano, Y1
Iwai, T1
Yamada, T1
Miyata, K1
Liao, S1
Wang, G1
Zhu, H1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Effect of Short Course Out-patient Pulmonary Rehabilitation on the Activity and Frequency of Exacerbations of Patients With Chronic Obstructive Pulmonary Disease.[NCT02471235]136 participants (Actual)Interventional2015-07-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for sulfur dioxide and Airflow Obstruction, Chronic

ArticleYear
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
Exposures and health outcomes from outdoor air pollutants in China.
    Toxicology, 2004, May-20, Volume: 198, Issue:1-3

    Topics: Adult; Air Pollutants; Child; China; Hospitalization; Humans; Lung Neoplasms; Middle Aged; Pulmonary

2004

Trials

2 trials available for sulfur dioxide and Airflow Obstruction, Chronic

ArticleYear
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
Community based integrated intervention for prevention and management of chronic obstructive pulmonary disease (COPD) in Guangdong, China: cluster randomised controlled trial.
    BMJ (Clinical research ed.), 2010, Dec-01, Volume: 341

    Topics: Administration, Inhalation; Adult; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Bronchodi

2010

Other Studies

36 other studies available for sulfur dioxide and Airflow Obstruction, Chronic

ArticleYear
Short-Term Air Pollution Exposure and Risk of Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Korea: A National Time-Stratified Case-Crossover Study.
    International journal of environmental research and public health, 2022, 02-28, Volume: 19, Issue:5

    Topics: Adult; Air Pollutants; Air Pollution; Cross-Over Studies; Environmental Exposure; Female; Humans; Ma

2022
Acute Effects of Air Pollution on Hospital Admissions for Asthma, COPD, and Bronchiectasis in Ahvaz, Iran.
    International journal of chronic obstructive pulmonary disease, 2020, Volume: 15

    Topics: Age Factors; Air Pollutants; Air Pollution; Asthma; Bronchiectasis; Carbon Monoxide; Hospitalization

2020
Predicting the morbidity of chronic obstructive pulmonary disease based on multiple locally weighted linear regression model with K-means clustering.
    International journal of medical informatics, 2020, Volume: 139

    Topics: Air Pollutants; Carbon Monoxide; China; Humans; Incidence; Linear Models; Models, Statistical; Morbi

2020
Association of time-serial changes in ambient particulate matters (PMs) with respiratory emergency cases in Taipei's Wenshan District.
    PloS one, 2017, Volume: 12, Issue:7

    Topics: Age Factors; Aged; Air Pollutants; Air Pollution; Asthma; Cities; Emergency Service, Hospital; Human

2017
Impact of Air Pollution and Outdoor Temperature on the Rate of Chronic Obstructive Pulmonary Disease Exacerbations.
    Folia medica, 2017, Dec-20, Volume: 59, Issue:4

    Topics: Aged; Air Pollution; Female; Humans; Male; Middle Aged; Nitrogen Dioxide; Particulate Matter; Pulmon

2017
A Multicity Analysis of the Short-Term Effects of Air Pollution on the Chronic Obstructive Pulmonary Disease Hospital Admissions in Shandong, China.
    International journal of environmental research and public health, 2018, 04-17, Volume: 15, Issue:4

    Topics: Aged; Air Pollutants; Air Pollution; China; Cities; Female; Hospitalization; Humans; Male; Nitrogen

2018
Effect of Air Pollution on Exacerbations of Bronchiectasis in Badalona, Spain, 2008-2016.
    Respiration; international review of thoracic diseases, 2018, Volume: 96, Issue:2

    Topics: Aged; Air Pollutants; Air Pollution; Asthma; Bronchiectasis; Emergency Service, Hospital; Female; Ho

2018
Ambient air pollution of particles and gas pollutants, and the predicted health risks from long-term exposure to PM
    Environmental science and pollution research international, 2018, Volume: 25, Issue:24

    Topics: Air Pollutants; Air Pollution; Cerebrovascular Disorders; China; Environmental Exposure; Humans; Lun

2018
Spatial patterns and effects of air pollution and meteorological factors on hospitalization for chronic lung diseases in Beijing, China.
    Science China. Life sciences, 2019, Volume: 62, Issue:10

    Topics: Air Pollutants; Air Pollution; Beijing; Environmental Exposure; Geography; Hospitalization; Humans;

2019
Long-term exposure to outdoor air pollution and the incidence of chronic obstructive pulmonary disease in a national English cohort.
    Occupational and environmental medicine, 2015, Volume: 72, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Anacardic Acids; Cohort Studies; Engl

2015
Effect of exposure to O₃ , NO₂, and SO₂ on chronic obstructive pulmonary disease hospitalizations in Tabriz, Iran.
    Environmental science and pollution research international, 2015, Volume: 22, Issue:4

    Topics: Air Pollutants; Air Pollution; Cities; Environmental Exposure; Hospitalization; Humans; Iran; Nitrog

2015
A GIS-based spatial correlation analysis for ambient air pollution and AECOPD hospitalizations in Jinan, China.
    Respiratory medicine, 2015, Volume: 109, Issue:3

    Topics: Aged; Aged, 80 and over; Air Pollutants; Air Pollutants, Occupational; Air Pollution; Carbon Monoxid

2015
Coarse Particulate Air Pollution Associated with Increased Risk of Hospital Admissions for Respiratory Diseases in a Tropical City, Kaohsiung, Taiwan.
    International journal of environmental research and public health, 2015, Oct-16, Volume: 12, Issue:10

    Topics: Air Pollution; Asthma; Carbon Monoxide; Cities; Cross-Over Studies; Hospitalization; Humans; Lung Di

2015
Evaluation of Chronic Obstructive Pulmonary Disease (COPD) attributed to atmospheric O3, NO2, and SO2 using Air Q Model (2011-2012 year).
    Environmental research, 2016, Volume: 144, Issue:Pt A

    Topics: Air Pollutants; Humans; Iran; Models, Theoretical; Nitrogen Dioxide; Ozone; Pulmonary Disease, Chron

2016
The burden of COPD mortality due to ambient air pollution in Guangzhou, China.
    Scientific reports, 2016, 05-19, Volume: 6

    Topics: Air Pollution; China; Environmental Exposure; Female; Humans; Male; Mortality; Nitrogen Dioxide; Non

2016
Short-term exposure to high ambient air pollution increases airway inflammation and respiratory symptoms in chronic obstructive pulmonary disease patients in Beijing, China.
    Environment international, 2016, Volume: 94

    Topics: Aged; Air Pollutants; Air Pollution; Beijing; Biomarkers; Dyspnea; Environmental Exposure; Female; H

2016
Exacerbations of Chronic Obstructive Pulmonary Disease (COPD): An Ecological Study in the Basque Country, Spain (2000-2011).
    COPD, 2016, Volume: 13, Issue:6

    Topics: Age Factors; Aged; Aged, 80 and over; Air Pollutants; Carbon Monoxide; Cities; Disease Progression;

2016
Association between Air Pollution and Hemoptysis.
    Canadian respiratory journal, 2016, Volume: 2016

    Topics: Adult; Aged; Air Pollution; Bronchial Arteries; Bronchiectasis; Carbon Monoxide; Embolization, Thera

2016
Low level air pollution and exacerbation of existing copd: a case crossover analysis.
    Environmental health : a global access science source, 2016, 10-18, Volume: 15, Issue:1

    Topics: Aged; Air Pollutants; Air Pollution; Environmental Monitoring; Female; Humans; Humidity; Influenza,

2016
Impact of Air Pollutants on Outpatient Visits for Acute Respiratory Outcomes.
    International journal of environmental research and public health, 2017, 01-05, Volume: 14, Issue:1

    Topics: Acute Disease; Air Pollutants; Air Pollution; Ambulatory Care; Asthma; Bronchitis; Carbon Monoxide;

2017
Short-term association between air pollution and emergency room admissions for chronic obstructive pulmonary disease in Nis, Serbia.
    Central European journal of public health, 2009, Volume: 17, Issue:1

    Topics: Air Pollutants; Emergency Service, Hospital; Hospitalization; Humans; Poisson Distribution; Pulmonar

2009
Urban air pollution and chronic obstructive pulmonary disease-related emergency department visits.
    Journal of epidemiology and community health, 2009, Volume: 63, Issue:10

    Topics: Adult; Air Pollutants; Air Pollution; Brazil; Carbon Monoxide; Emergency Service, Hospital; Environm

2009
Outdoor air pollution is associated with rapid decline of lung function in alpha-1-antitrypsin deficiency.
    Occupational and environmental medicine, 2010, Volume: 67, Issue:8

    Topics: Air Pollution; alpha 1-Antitrypsin Deficiency; Female; Forced Expiratory Volume; Humans; Male; Middl

2010
[Consequences of atmospheric pollution fluctuations in patients with COPD].
    Revue des maladies respiratoires, 2010, Volume: 27, Issue:8

    Topics: Acute Disease; Air Pollutants; Air Pollution; Animals; Bronchoconstriction; Cardiovascular Diseases;

2010
Effect of dust storm events on daily emergency admissions for respiratory diseases.
    Respirology (Carlton, Vic.), 2012, Volume: 17, Issue:1

    Topics: Air Pollutants; Air Pollution; Cardiovascular Diseases; Disasters; Dust; Female; Hong Kong; Hospital

2012
Effects of coarse particulate matter on emergency hospital admissions for respiratory diseases: a time-series analysis in Hong Kong.
    Environmental health perspectives, 2012, Volume: 120, Issue:4

    Topics: Air Pollutants; Asthma; Hong Kong; Hospitalization; Humans; Nitrogen Dioxide; Ozone; Particle Size;

2012
The effects of air pollution on acute respiratory conditions.
    Respirology (Carlton, Vic.), 2003, Volume: 8, Issue:2

    Topics: Adult; Aged; Air Pollutants; Analysis of Variance; Asthma; Carbon Monoxide; Emergency Service, Hospi

2003
Respiratory effects of sulphur dioxide: a hierarchical multicity analysis in the APHEA 2 study.
    Occupational and environmental medicine, 2003, Volume: 60, Issue:8

    Topics: Adolescent; Adult; Age Distribution; Aged; Air Pollution; Asthma; Child; Child, Preschool; Female; H

2003
[Time-series analysis on the relationship between air pollution and daily mortality in Beijing].
    Wei sheng yan jiu = Journal of hygiene research, 2003, Volume: 32, Issue:6

    Topics: Air Pollutants; Carbon Monoxide; Cause of Death; China; Coronary Disease; Humans; Particle Size; Poi

2003
Emergency department visits and "vog"-related air quality in Hilo, Hawai'i.
    Environmental research, 2004, Volume: 95, Issue:1

    Topics: Air Pollutants; Asthma; Common Cold; Emergency Service, Hospital; Environmental Monitoring; Epidemio

2004
Ambient air pollution and cardiovascular emergency department visits in potentially sensitive groups.
    American journal of epidemiology, 2007, Mar-15, Volume: 165, Issue:6

    Topics: Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Comorbidity; Cross-Over Studies; Diabetes C

2007
Temporal relationship between air pollutants and hospital admissions for chronic obstructive pulmonary disease in Hong Kong.
    Thorax, 2007, Volume: 62, Issue:9

    Topics: Air Pollutants; Air Pollution; Hong Kong; Hospitalization; Humans; Nitric Oxide; Ozone; Particulate

2007
Air pollution and hospital admissions for chronic obstructive pulmonary disease in a tropical city: Kaohsiung, Taiwan.
    Inhalation toxicology, 2007, Volume: 19, Issue:5

    Topics: Air Pollution; Carbon Monoxide; Cross-Over Studies; Hospitalization; Humans; Nitrogen Dioxide; Odds

2007
Effect of YM-40461, a novel surfactant secretagogue, on chronic obstructive pulmonary diseases and similar symptoms in guinea pigs.
    Arzneimittel-Forschung, 2001, Volume: 51, Issue:9

    Topics: Acetylcholine; Animals; Blood Gas Analysis; Bronchial Hyperreactivity; Bronchitis; Guinea Pigs; Hypo

2001
Establishment and pathological study of models of chronic obstructive pulmonary disease by SO2 inhalation method.
    Chinese medical journal, 2000, Volume: 113, Issue:3

    Topics: Administration, Inhalation; Animals; Disease Models, Animal; Lung; Male; Maximal Expiratory Flow Rat

2000
Effect of ipratropium bromide on airway and pulmonary muscarinic receptors in a rat model of chronic obstructive pulmonary disease.
    Chinese medical journal, 2001, Volume: 114, Issue:1

    Topics: Animals; Bronchodilator Agents; Disease Models, Animal; Ipratropium; Lung; Male; Muscarinic Antagoni

2001